Posts tagged ‘Social Media’
May 13th, 2011
Sally Church is recognized as influential in pharma social media circles. She’s appeared on CNBC to talk about FDA Social Media Guidance, and has been recognized as one of the leading women of Twitter.
She frequently writes on Pharma Strategy Blog about what’s happening in the fast paced world of social media, and the impact this may have on the pharmaceutical industry.
In a recent blog post on “mobile health and the impact for pharma“, Sally looks at research published earlier this week by the Pew Internet & American Life Project on “how social media is changing the way we interact and do a lot of things.”
Sally discusses in her post on Pharma Strategy Blog the key trends highlighted by the Pew research and the opportunities this presents for Pharma marketing.
The fact that more of us are gathering health information online has important implications for Pharma and their agencies. Sally offers insight into where the opportunities are for pharma social media strategy development.
Pieter Droppert on Biotech Strategy Blog has also looked at the Pew Survey, and picks up on how video is becoming increasingly important in the search for health information. Pieter previously wrote about the opportunities for using video to recruit for cancer clinical trials.
You can read Pieter’s post on “how people are using social media to find health information” on Biotech Strategy Blog.
May 4th, 2011
Sally is well known within Pharma social media circles and has also appeared on CNBC to talk about FDA Social Media policy.
We applaud Sally for all her engagement in social media that reflects her passion and knowledge about the pharmaceutical industry and in particular oncology, hematology science, marketing and new product development.
If you have a forthcoming conference, Sally is available for speaking opportunities to share her insight about social media strategy and marketing in the pharma industry.
April 22nd, 2011
One of the rate limiting steps in bringing new drugs to market is the time to accrue patients into clinical trials for registration. As the use of social media continues to evolve in the pharmaceutical industry, one area where it may have an impact is to educate patients about clinical research, and share information on trials that are enrolling.
Pieter Droppert on Biotech Strategy Blog looks at the use of social media in cancer treatment. It is estimated that only 3-5% of cancer patients participate in clinical trials.
Using Storify, a new online tool that aggregates information across various social media such as Twitter, Facebook, YouTube, Pieter looks at how social media is being for clinical trial education and recruitment. You can read more on Biotech Strategy Blog.
April 7th, 2011
At the recent annual meeting of the American Association for Cancer Research (AACR), Icarus Consultant’s oncology expert and social media guru generated video highlights for Pharma Strategy Blog; a first for Sally and no mean feat to shoot a video blog (vblog) after a full day at a conference.
In case you missed the videos, you can watch them below:
Day 1 highlights of the AACR Annual Meeting by Sally Church, PhD include how to use Twitter to keep in touch with breaking news at a meeting such as AACR, and what Sally thinks will be hot news.
Day 2 highlights of the AACR Annual Meeting by Sally Church, PhD include commentary on the plenary presentation by Dr Harold Varmus of the National Cancer Institute (NCI), exciting phase II data on GDC-0449, a hedgehog pathway inhibitor for the prevention of basal cell carcinoma in basal cell nevus syndrome (BCNS) patients, and the launch of a new journal, Cancer Discovery, by AACR.
You can read more about the AACR annual meeting on Pharma Strategy Blog.
February 23rd, 2011
All those in the pharma/biotech industry who perform market research will be familiar with ESOMAR, the worldwide organization whose code of practice governs how we conduct market research.
So, we are pleased to be invited to the ESOMAR – Best of New York, 2011 event to be held at the offices of Microsoft in NYC, later today. Networking opportunities are always welcome, and Pieter Droppert from Icarus will be attending.
The meeting has four speakers covering a wide range of topics, including employing robots to mine twitter, and how to draw on the wisdom of crowds to generate winning concepts. It is good to have an opportunity to hear what other market research practitioners are doing outside of the pharma/biotech industry.
Information about the key opinion leader (KOL) market research services that Icarus Consultants offers can be found here.
December 21st, 2010
Thanks to Priya Kapor of Ogilvy PR for including Pharma Strategy Blog as one her 11 Pharma Blogs for 2011 that have “not only walked the walk but have helped shaped this space in the past year and most likely will moving into 2011.”